Intellia Therapeutics Inc (NTLA) USD0.0001
1.49%- This stock can be held in a
Stocks and Shares ISASell:$11.90
Buy:$12.20
Change:
$0.17
(1.40%)
$0.17
(1.40%)Market closed | Prices delayed by at least 15 minutes
Sell:$11.90
Buy:$12.20
Change:$0.17
(1.40%)
$0.17
(1.40%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 2 October 2024 | Michael P DubeChief Accounting Officer | Sell Tax related | 2,012 | $19.01 | $38,248.12 | 47,012 |
| 1 July 2024 | Eliana ClarkCTO | Sell Regular sell transaction (market) | 405 | $22.93 | $9,286.65 | 71,470 |
| 17 June 2024 | Frank VerwielChairman of the Board | Sell Regular sell transaction (market) | 1,505 | $25.00 | $37,625.00 | 17,948 |
| 4 March 2024 | James (Jim) BastaExecutive Vice President | Sell Tax related | 2,297 | $32.99 | $75,778.03 | 81,571 |
| 4 March 2024 | Eliana ClarkCTO | Sell Tax related | 605 | $32.99 | $19,958.95 | 71,470 |
| 8 January 2024 | Laura Sepp-LorenzinoChief Level Officer | Sell Regular sell transaction (market) | 1,608 | $28.66 | $46,085.28 | 44,594 |
| 8 January 2024 | Laura Sepp-LorenzinoChief Level Officer | Sell Regular sell transaction (market) | 667 | $29.38 | $19,596.46 | 43,927 |
| 3 January 2024 | John M LeonardPresident/CEO | Sell Tax related | 19,223 | $29.46 | $566,309.58 | 846,486 |
| 3 January 2024 | David LebwohlOther Level A | Sell Tax related | 5,843 | $29.46 | $172,134.78 | 54,372 |
| 3 January 2024 | James (Jim) BastaExecutive Vice President | Sell Tax related | 3,805 | $29.46 | $112,095.30 | 51,474 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 3 January 2024 | John M LeonardPresident/CEO | Sell Tax related | 19,223 | $29.46 | $566,309.58 | 846,486 |
| 3 January 2024 | David LebwohlOther Level A | Sell Tax related | 5,843 | $29.46 | $172,134.78 | 54,372 |
| 3 January 2024 | Laura Sepp-LorenzinoChief Level Officer | Sell Tax related | 5,532 | $29.46 | $162,972.72 | 46,202 |
| 3 January 2024 | Glenn G. GoddardCFO | Sell Tax related | 5,365 | $29.46 | $158,052.90 | 40,585 |
| 3 January 2024 | Eliana ClarkCTO | Sell Tax related | 4,301 | $29.46 | $126,707.46 | 40,845 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.